Ginger supplementation reduced CRP in subjects with type 2 diabetes (1.6–3 g/d for 12 wk) (35, 36) and nonalcoholic fatty liver disease (2 g/d for 12 wk) (37). This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.